ACTIVExtend trial demonstrated sustained statistically significant fracture risk reduction through the 3.5 years of ...
CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its ...
EDMONTON, Alberta, Sept. 14, 2017 (GLOBE NEWSWIRE) -- The Alberta Medical Association (AMA) will ...
